"Prurisol is really the first trial that will give us an indication if Menon is the wizard he is known to be when it comes to interpreting pre-clinical results in terms of impacts on humans"
I respectfully have to disagree with this assessment. I view the the successful Phase I Kevetrin trial and the fact that we have multiple Phase II studies lined up + multiple orphan drug designations as Dr. Mennon's skill and knowledge being touted. Secondly, they tweaked Brilacidin so no more concerns about safety while managing to maintain its efficacy.
My .02
(0)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.